Ophthalmic Drugs And What They Say About EU Antitrust
Law360, New York (May 29, 2014, 1:21 PM EDT) -- The European Commission and the national competition authorities of the member states of the European Economic Area have progressively broadened the scope of their cooperation in the enforcement of competition rules. The recent investigations into two pharmaceutical companies active in the ophthalmic drugs market in Europe serve as a reminder of such strengthened cross-border cooperation and the risk of potential parallel proceedings in several jurisdictions. International groups should therefore build efficient global coordination among the local teams and offices under a single antitrust audit and compliance strategy, taking into account the specificities of each jurisdiction where they have a presence or do business....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
